Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
09/05/201819h28Dow Jones NewsMylan May Be Gem in Rough Generic SectorNYSE:TEVATeva Pharmaceutical Industries Ltd
09/05/201809h02Dow Jones NewsCalifornia Counties Jump Into Litigation -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
08/05/201822h00Dow Jones NewsCalifornia Counties Jump Into Opioid Litigation -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
08/05/201821h44Dow Jones NewsCalifornia Counties Jump Into Opioid LitigationNYSE:TEVATeva Pharmaceutical Industries Ltd
04/05/201823h31Dow Jones NewsADRs End Higher; Alibaba RisesNYSE:TEVATeva Pharmaceutical Industries Ltd
04/05/201800h06Dow Jones NewsADRs End Mostly Higher; Smith & Nephew FallsNYSE:TEVATeva Pharmaceutical Industries Ltd
03/05/201814h21Dow Jones NewsTeva Raises Outlook After 1Q ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
03/05/201813h00Business WireTeva Reports First Quarter 2018 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
03/05/201809h02Dow Jones NewsNew Front in Opioid Lawsuits: Rise in Insurance Premiums -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
02/05/201819h13Dow Jones NewsNew Front on Opioid Litigation: Suits Over Rising PremiumsNYSE:TEVATeva Pharmaceutical Industries Ltd
02/05/201814h00Business WireTeva to Present AUSTEDO® (deutetrabenazine) Tablets Data at the American Psychiatric Association 2018 Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
27/04/201821h50Business WireTeva Presents New Long-Term Data Demonstrating Efficacy and Safety of COPAXONE® (glatiramer acetate injection) 40 mg/mLNYSE:TEVATeva Pharmaceutical Industries Ltd
23/04/201814h30Business WireTeva to Report First Quarter 2018 Financial Results on May 3, 2018NYSE:TEVATeva Pharmaceutical Industries Ltd
19/04/201813h00Business WireTeva and the Procter & Gamble Company Have Agreed to Terminate the PGT Healthcare PartnershipNYSE:TEVATeva Pharmaceutical Industries Ltd
17/04/201814h00Business WireTeva to Present New Data Across Multiple Therapeutic Areas at 70th Annual Meeting of the American Academy of NeurologyNYSE:TEVATeva Pharmaceutical Industries Ltd
05/04/201808h49Dow Jones NewsIndivior Sues Companies for Suboxone Copyright InfringementNYSE:TEVATeva Pharmaceutical Industries Ltd
26/03/201820h49Business WireTeva Announces the Launch of a Generic Version of Lialda® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
23/03/201818h27Business WireTeva Announces the Launch of a Generic Version of ALOXI® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
12/03/201813h40Business WireTeva to Present at the Cowen & Company 38th Annual Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
07/03/201822h14Business WireTeva Announces Upsizing and Successful Pricing of $4.5 Billion of Senior NotesNYSE:TEVATeva Pharmaceutical Industries Ltd
28/02/201815h00Business WireTeva Announces Launch of Offering of Senior NotesNYSE:TEVATeva Pharmaceutical Industries Ltd
20/02/201817h03Business WireTeva Announces Exclusive Launch of Two Strengths of a Generic Version of Solodyn® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
16/02/201817h39Business WireTeva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation AerosolNYSE:TEVATeva Pharmaceutical Industries Ltd
09/02/201815h00Business WireTeva Announces Launch of a Generic Version of Syprine® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
09/02/201809h02Dow Jones NewsTeva Sustains $11.6 Billion Loss -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
08/02/201820h24Dow Jones NewsTeva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook WarningNYSE:TEVATeva Pharmaceutical Industries Ltd
08/02/201813h00Business WireTeva Reports 2017 Full Year and Fourth Quarter Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
02/02/201813h00Business WireEuropean Medicines Agency (EMA) Accepts Fremanezumab Marketing Authorization ApplicationNYSE:TEVATeva Pharmaceutical Industries Ltd
01/02/201814h26Business WireTeva Completes Amendment to Credit FacilitiesNYSE:TEVATeva Pharmaceutical Industries Ltd
01/02/201813h00Business WireTeva Announces Completion of Global Women’s Health Divestiture to CVC Capital PartnersNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA